| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 80.46B | 74.20B | 67.36B | 55.63B | 44.43B |
| Gross Profit | 66.97B | 60.76B | 55.59B | 50.68B | 44.57B |
| EBITDA | 15.57B | 14.57B | 12.16B | 11.21B | 12.38B |
| Net Income | 10.83B | 10.13B | 8.37B | 7.51B | 8.06B |
Balance Sheet | |||||
| Total Assets | 300.05B | 271.46B | 261.11B | 228.35B | 188.55B |
| Cash, Cash Equivalents and Short-Term Investments | 48.53B | 41.74B | 48.65B | 38.39B | 24.50B |
| Total Debt | 57.76B | 51.09B | 49.16B | 43.92B | 40.92B |
| Total Liabilities | 266.58B | 241.20B | 233.05B | 203.64B | 166.37B |
| Stockholders Equity | 33.47B | 30.26B | 28.06B | 24.71B | 22.18B |
Cash Flow | |||||
| Free Cash Flow | 16.00B | 12.14B | 17.00B | 19.22B | 13.10B |
| Operating Cash Flow | 18.43B | 14.05B | 18.56B | 21.08B | 14.64B |
| Investing Cash Flow | -22.89B | -24.40B | -24.43B | -33.69B | -10.53B |
| Financing Cash Flow | 11.21B | 4.44B | 18.38B | 24.51B | -14.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $581.16B | 28.66 | 54.22% | 0.69% | 11.34% | 2.76% | |
74 Outperform | $448.37B | 31.53 | 198.42% | 0.54% | 15.67% | 18.22% | |
68 Neutral | $206.15B | 23.73 | 33.49% | 0.84% | 8.14% | 9.55% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $23.51B | 8.41 | 21.09% | 1.34% | -6.38% | 19.65% | |
66 Neutral | $41.29B | 10.70 | 25.87% | ― | 4.50% | 19.71% | |
53 Neutral | $115.20B | 53.42 | 2.44% | 1.05% | 19.39% | -77.61% |